EMILIN2 Antibody (828B3B3) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-36064F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunohistochemistry-Frozen, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2 kappa Clone # 828B3B3
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for EMILIN2 Antibody (828B3B3) [FITC]
Immunogen
Recombinant gC1q domain of EMILIN2
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2 kappa
Applications for EMILIN2 Antibody (828B3B3) [FITC]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Frozen
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: EMILIN2
Long Name
Elastin Microfibril Interfacer 2
Alternate Names
EMIL2, FLJ33200, FOAP-10
Gene Symbol
EMILIN2
Additional EMILIN2 Products
Product Documents for EMILIN2 Antibody (828B3B3) [FITC]
Product Specific Notices for EMILIN2 Antibody (828B3B3) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...